Brainstorm Cell Therapeutics Stock (NASDAQ:BCLI)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.33

52W Range

$1.95 - $11.85

50D Avg

$4.25

200D Avg

$5.74

Market Cap

$12.28M

Avg Vol (3M)

$31.72K

Beta

0.32

Div Yield

-

BCLI Company Profile


Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

29

IPO Date

Oct 07, 2003

Website

BCLI Performance


BCLI Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income-$-24.82M$-24.54M
Net Income-$-23.73M$-24.38M
EBITDA-$-24.82M$-24.28M
Basic EPS-$-0.65$-0.67
Diluted EPS-$-0.65$-0.67

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 14, 24 | 12:08 PM
Q3 23Nov 14, 23 | 12:20 PM
Q2 23Aug 14, 23 | 11:03 AM

Peer Comparison


TickerCompany
CKPTCheckpoint Therapeutics, Inc.
GRIGRI Bio, Inc.
CUECue Biopharma, Inc.
XFORX4 Pharmaceuticals, Inc.
GMDAGamida Cell Ltd.
DBTXDecibel Therapeutics, Inc.
MREOMereo BioPharma Group plc
ALDXAldeyra Therapeutics, Inc.
BCABBioAtla, Inc.
DAWNDay One Biopharmaceuticals, Inc.
EWTXEdgewise Therapeutics, Inc.
GBIOGeneration Bio Co.
CRVSCorvus Pharmaceuticals, Inc.
TERNTerns Pharmaceuticals, Inc.
CNTBConnect Biopharma Holdings Limited
PASGPassage Bio, Inc.
INZYInozyme Pharma, Inc.
ANTXAN2 Therapeutics, Inc.
HCWBHCW Biologics Inc.
CCCCC4 Therapeutics, Inc.
HOWLWerewolf Therapeutics, Inc.
TRVITrevi Therapeutics, Inc.
LIFEaTyr Pharma, Inc.
CELCCelcuity Inc.